Nasopharyngeal carcinoma radiotherapy with hybrid technique

被引:17
|
作者
Akbas, Ugur [1 ]
Koksal, Canan [1 ]
Kesen, Nazmiye Donmez [1 ]
Ozkaya, Kubra [2 ]
Bilge, Hatice [1 ]
Altun, Musa [2 ]
机构
[1] Istanbul Univ, Oncol Inst, Div Med Phys, Istanbul, Turkey
[2] Istanbul Univ, Med Fac, Div Radiat Oncol, Istanbul, Turkey
关键词
Nasopharyngeal cancer; IMRT; VMAT; Hybrid; MODULATED ARC THERAPY; RADIATION-THERAPY; IMRT; TUMOR; VMAT;
D O I
10.1016/j.meddos.2018.09.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the study was to investigate the effect of the Hybrid technique which was created by combining of intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) for the treatment of nasopharyngeal cancer (NPC) patients. 7 to 9 field IMRT, triple arc VMAT, and Hybrid plans were generated for 10 advanced stage NPC patients. The homogeneity index (HI) and the conformity index (CI) of planning target volumes (PTVs) were calculated for each technique to evaluate the plan quality. The techniques were compared in terms of plan quality, sparing of organs at risk (OARs), monitor units (MUs), and delivery time. Hybrid technique significantly improved the target dose homogeneity and the conformity for PTV70 and PTV60 compared to IMRT and VMAT. Hybrid plans significantly reduced the maximum dose of the brainstem sparing compared to the VMAT plans and also improved the sparing of spinal cord compared to IMRT and VMAT. The MUs and the delivery time of Hybrid plans were found to be between values for IMRT and VMAT plans. Hybrid technique can be useful when IMRT and VMAT techniques are not adequate alone in the treatment of NPC patients. (C) 2018 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:251 / 257
页数:7
相关论文
共 50 条
  • [31] RADICAL RADIOTHERAPY IN ELDERLY PATIENTS WITH NASOPHARYNGEAL CARCINOMA
    Sze, H.
    Ng, W. T.
    Yau, T. K.
    Lee, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S328 - S328
  • [32] Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma
    Enkelejda Lamaj
    Erwin Vu
    Janita E. van Timmeren
    Chiara Leonardi
    Louise Marc
    Izabela Pytko
    Matthias Guckenberger
    Panagiotis Balermpas
    Radiation Oncology, 16
  • [33] Stereotactic radiotherapy for locally recurrent nasopharyngeal carcinoma
    Mitsuhashi, N
    Sakurai, H
    Katano, S
    Kurosaki, H
    Hasegawa, M
    Akimoto, T
    Nozaki, M
    Hayakawa, K
    Niibe, H
    LARYNGOSCOPE, 1999, 109 (05): : 805 - 809
  • [34] Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma
    Vu, E.
    Lamaj, E.
    van Timmeren, J.
    Leonardi, C.
    Pytko, I.
    Marc, L.
    Guckenberger, M.
    Balermpas, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S849 - S850
  • [35] Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma
    Lamaj, Enkelejda
    Vu, Erwin
    van Timmeren, Janita E.
    Leonardi, Chiara
    Marc, Louise
    Pytko, Izabela
    Guckenberger, Matthias
    Balermpas, Panagiotis
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [36] Postradiation sarcoma after radiotherapy for nasopharyngeal carcinoma
    Chan, Jimmy Yu Wai
    Wong, Stanley Thian Sze
    Lau, Gregory Ian Siu Kee
    Wei, William Ignace
    LARYNGOSCOPE, 2012, 122 (12): : 2695 - 2699
  • [37] Tension Pneumocephalus Related to Radiotherapy for Nasopharyngeal Carcinoma
    Jimenez-Jimenez, Esther
    Sabater Marti, Sebastia
    Victoria Villas, M.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [38] AFTERLOADING RADIOTHERAPY FOR LOCAL PERSISTENCE OF NASOPHARYNGEAL CARCINOMA
    TEO, P
    LEUNG, SF
    CHOI, P
    LEE, WY
    JOHNSON, PJ
    BRITISH JOURNAL OF RADIOLOGY, 1994, 67 (794): : 181 - 185
  • [39] MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy
    Ng, SH
    Wan, YL
    Ko, SF
    Chang, JT
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 1998, 8 (02) : 327 - 336
  • [40] Management of hypothyroidism after radiotherapy for nasopharyngeal carcinoma
    Garfield, David H.
    Hercbergs, Aleck
    Davis, Paul
    MEDICAL ONCOLOGY, 2008, 25 (04) : 474 - 475